Co-Founder and COO of Compass Pathways, Lars Wilde, discusses his journey to secure funding for his psilocybin therapy for treatment-resistant depression. What made him so successful? Listen now to find out.

Addressing Investor Risks

Jan 15th, 2019 5m 9s

Investors expressed two risks to Peter Strumph regarding his pitch. In this episode, Peter talks about how he addressed and overcame these risks during funding conversations, and the lessons he learned along the way.

Innovation: Do Investors Really Care?

Jan 15th, 2019 5m 7s

In this episode, Peter reveals what surprised him most: the buzz surrounding innovation. So many people claim that it makes or breaks a funding deal, but does it? Peter talks about how he approached this when preparing his funding strategy.

Producing a Winning Presentation

Jan 15th, 2019 4m 52s

What kind of presentation intrigues investors? What parts of Peter’s presentation were so successful? Uncover how one pharmaceutical executive created a presentation that ultimately won the business of investors.

How to Manage the Challenges in Early Phase Oncology Clinical Trials

Oct 29th, 2018 5m 6s

Meghann Howland, Vice President, Therapeutic Strategy Lead, Oncology, at Worldwide Clinical Trials, discusses the challenges of managing an early phase oncology clinical trial, and how the right contract research organization (CRO) can be a val

Alzheimer’s Disease: We’re Not About to Give Up Now

Oct 29th, 2018 4m 59s

The scientific, medical, and operational experts at Worldwide Clinical Trials’ have been leading Alzheimer’s disease research since the advent of cholinesterase inhibitors as a cognitive therapeutic in the late 1970s. It’s been a long road on t

The Key to Conducting a Successful Early Phase Clinical Trial

Oct 28th, 2018 4m 22s

Early phase research involves constantly moving elements, including toxicology results, regulatory requirements, program optimization, study design strategy and drug readiness. Initial human data are a critical development milestone. Our early

Rate